Literature DB >> 7982657

Fructose metabolism and cell survival in freshly isolated rat hepatocytes incubated under hypoxic conditions: proposals for potential clinical use.

V Lefebvre1, I Goffin, P Buc-Calderon.   

Abstract

The protective effect of fructose with regard to hypoxia-induced cell injury was investigated. The addition of fructose (2 to 20 mmol/L) protected hepatocytes against hypoxia-mediated cell lysis in a concentration-dependent way. The intracellular ATP content was initially decreased as a result of fructose-1-phosphate formation, but it remained constant during the hypoxic incubation. Conversely, high initial ATP values observed at low fructose concentrations progressively declined. Cellular protection was observed only when fructose was added before (and not after) the start of hypoxia. In addition, a sufficient amount of fructose-1-phosphate rapidly accumulated before the induction of hypoxia, and the linear production of lactate, during hypoxic incubation, indicated that cells synthesized ATP continuously. The lack of cell protection by fructose added after the onset of the hypoxia may be explained by a lesser fructose-1-phosphate formation and a subsequently low accumulation leading to insufficient glycolytic ATP production. Under aerobic conditions, both glycolysis (lactate formation) and gluconeogenesis (glucose formation) were carried out in fructose-1-phosphate-loaded cells with the same initial rates, whereas under hypoxic conditions glycolysis was the main metabolic event. The fact that protein synthesis activity recovered faster during reoxygenation of previously hypoxic fructose-treated cells than in glucose-treated cells led us to hypothesize that in situ perfusion of liver with fructose, before its removal, would improve its metabolic capacity during the hypoxic cold preservation and subsequent transplantation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7982657     DOI: 10.1002/hep.1840200628

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  3 in total

1.  Persistence of a chimerical phenotype after hepatocyte differentiation of human bone marrow mesenchymal stem cells.

Authors:  P A Lysy; D Campard; F Smets; J Malaise; M Mourad; M Najimi; E M Sokal
Journal:  Cell Prolif       Date:  2008-02       Impact factor: 6.831

2.  Continous, non-invasive monitoring of oxygen consumption in a parallelized microfluidic in vitro system provides novel insight into the response to nutrients and drugs of primary human hepatocytes.

Authors:  Marius Busche; Dominik Rabl; Jan Fischer; Christian Schmees; Torsten Mayr; Rolf Gebhardt; Martin Stelzle
Journal:  EXCLI J       Date:  2022-01-07       Impact factor: 4.068

3.  4-Aminoethylamino-emodin--a novel potent inhibitor of GSK-3beta--acts as an insulin-sensitizer avoiding downstream effects of activated beta-catenin.

Authors:  Rolf Gebhardt; Katja S Lerche; Frank Götschel; Robert Günther; Jens Kolander; Lars Teich; Sebastian Zellmer; Hans-Jörg Hofmann; Kurt Eger; Andreas Hecht; Frank Gaunitz
Journal:  J Cell Mol Med       Date:  2009-10-03       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.